CN114794469A - Compositions for inhibiting melanin and uses and methods thereof - Google Patents
Compositions for inhibiting melanin and uses and methods thereof Download PDFInfo
- Publication number
- CN114794469A CN114794469A CN202210519924.7A CN202210519924A CN114794469A CN 114794469 A CN114794469 A CN 114794469A CN 202210519924 A CN202210519924 A CN 202210519924A CN 114794469 A CN114794469 A CN 114794469A
- Authority
- CN
- China
- Prior art keywords
- composition
- amount
- flour
- coconut
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 119
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 title claims abstract description 48
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims abstract description 18
- 235000013162 Cocos nucifera Nutrition 0.000 claims abstract description 56
- 244000060011 Cocos nucifera Species 0.000 claims abstract description 56
- 108060008724 Tyrosinase Proteins 0.000 claims abstract description 56
- 102000003425 Tyrosinase Human genes 0.000 claims abstract description 55
- 239000000843 powder Substances 0.000 claims abstract description 52
- 235000013312 flour Nutrition 0.000 claims abstract description 46
- 244000075850 Avena orientalis Species 0.000 claims abstract description 40
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 39
- 235000013339 cereals Nutrition 0.000 claims abstract description 37
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 27
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 22
- 235000009566 rice Nutrition 0.000 claims abstract description 22
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 21
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 19
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 18
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 239000011701 zinc Substances 0.000 claims abstract description 12
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 12
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 11
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 11
- 239000011570 nicotinamide Substances 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 235000001188 Peltandra virginica Nutrition 0.000 claims abstract description 5
- 240000007594 Oryza sativa Species 0.000 claims abstract 6
- 235000007558 Avena sp Nutrition 0.000 claims description 29
- 235000013305 food Nutrition 0.000 claims description 24
- 244000197580 Poria cocos Species 0.000 claims description 17
- 235000002723 Dioscorea alata Nutrition 0.000 claims description 14
- 235000007056 Dioscorea composita Nutrition 0.000 claims description 14
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 claims description 14
- 235000005362 Dioscorea floribunda Nutrition 0.000 claims description 14
- 235000004868 Dioscorea macrostachya Nutrition 0.000 claims description 14
- 235000005361 Dioscorea nummularia Nutrition 0.000 claims description 14
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 claims description 14
- 229940088594 vitamin Drugs 0.000 claims description 14
- 229930003231 vitamin Natural products 0.000 claims description 14
- 235000013343 vitamin Nutrition 0.000 claims description 14
- 239000011782 vitamin Substances 0.000 claims description 14
- 235000016709 nutrition Nutrition 0.000 claims description 10
- 239000011573 trace mineral Substances 0.000 claims description 10
- 235000013619 trace mineral Nutrition 0.000 claims description 10
- 241001506047 Tremella Species 0.000 claims description 9
- GCLCUMYFMBKDOS-UHFFFAOYSA-N pyridine-3-carboxamide;zinc Chemical compound [Zn].NC(=O)C1=CC=CN=C1 GCLCUMYFMBKDOS-UHFFFAOYSA-N 0.000 claims description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 241000234435 Lilium Species 0.000 claims description 7
- 240000002853 Nelumbo nucifera Species 0.000 claims description 7
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 7
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- 240000001417 Vigna umbellata Species 0.000 claims description 5
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 5
- 235000021329 brown rice Nutrition 0.000 claims description 5
- 235000013365 dairy product Nutrition 0.000 claims description 5
- 244000013123 dwarf bean Species 0.000 claims description 5
- 235000021278 navy bean Nutrition 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 244000046146 Pueraria lobata Species 0.000 claims description 4
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims description 3
- 239000003623 enhancer Substances 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 claims description 2
- 230000003061 melanogenesis Effects 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 abstract description 22
- 230000002087 whitening effect Effects 0.000 abstract description 8
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 39
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 24
- 241000209094 Oryza Species 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 239000002994 raw material Substances 0.000 description 15
- 210000003491 skin Anatomy 0.000 description 14
- 244000281702 Dioscorea villosa Species 0.000 description 13
- 239000000523 sample Substances 0.000 description 12
- 229960004441 tyrosine Drugs 0.000 description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 9
- -1 oxygen free radical Chemical class 0.000 description 9
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- 210000000582 semen Anatomy 0.000 description 9
- 239000002002 slurry Substances 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 7
- 229960004705 kojic acid Drugs 0.000 description 7
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 7
- 230000008099 melanin synthesis Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 208000003351 Melanosis Diseases 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- MKMCJLMBVKHUMS-UHFFFAOYSA-N Coixol Chemical compound COC1=CC=C2NC(=O)OC2=C1 MKMCJLMBVKHUMS-UHFFFAOYSA-N 0.000 description 4
- 235000002722 Dioscorea batatas Nutrition 0.000 description 4
- 240000001811 Dioscorea oppositifolia Species 0.000 description 4
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 4
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 4
- 241000209504 Poaceae Species 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 241000220485 Fabaceae Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 235000015982 Lilium brownii Nutrition 0.000 description 3
- 240000008058 Lilium brownii Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 241000908178 Tremella fuciformis Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 235000020197 coconut milk Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229910001431 copper ion Inorganic materials 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 235000021332 kidney beans Nutrition 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000013618 yogurt Nutrition 0.000 description 3
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 2
- 101000773083 Homo sapiens 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 2
- 101000796203 Homo sapiens L-dopachrome tautomerase Proteins 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940105039 coconut extract Drugs 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- 244000144619 Abrus precatorius Species 0.000 description 1
- 229940122816 Amylase inhibitor Drugs 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 235000005781 Avena Nutrition 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000737241 Cocos Species 0.000 description 1
- 241000209205 Coix Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000002156 Lilium lancifolium Nutrition 0.000 description 1
- 244000210789 Lilium lancifolium Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001257583 Microphyllum Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 240000001659 Oldenlandia diffusa Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 1
- 244000100170 Phaseolus lunatus Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 229930186706 Puerarin-xyloside Natural products 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241001474728 Satyrodes eurydice Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
- 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000003392 amylase inhibitor Substances 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000020415 coconut juice Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- RJKLDOLOCIQYFS-PRTISISMSA-N miroestrol Chemical compound C12=COC3=CC(O)=CC=C3[C@H]2C(C)(C)[C@@H]2[C@@H]([C@H]3O)[C@@]1(O)C(=O)C[C@]3(O)C2 RJKLDOLOCIQYFS-PRTISISMSA-N 0.000 description 1
- CKEZIBBDMDFHQQ-ILKNQKGPSA-N miroestrol Natural products CC1(C)[C@H]2C[C@]3(O)CC(=O)[C@H]([C@@H]2[C@H]3O)C4=COc5ccccc5[C@@H]14 CKEZIBBDMDFHQQ-ILKNQKGPSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- NAAXIGQVODQJOV-PXYOAQHISA-N puerarin xyloside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C1=C(C(C(C=2C=CC(O)=CC=2)=CO1)=O)C=C1)=C1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)CO1 NAAXIGQVODQJOV-PXYOAQHISA-N 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000021139 traditional diet Nutrition 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229940068096 zinc nicotinate Drugs 0.000 description 1
- VYAAXNAPTXCMLY-UHFFFAOYSA-L zinc;pyridine-3-carboxylate Chemical compound [Zn+2].[O-]C(=O)C1=CC=CN=C1.[O-]C(=O)C1=CC=CN=C1 VYAAXNAPTXCMLY-UHFFFAOYSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
- A23L7/126—Snacks or the like obtained by binding, shaping or compacting together cereal grains or cereal pieces, e.g. cereal bars
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a composition for inhibiting tyrosinase comprising grain in an amount of about 50 wt.% to about 95 wt.% and coconut flour in an amount of about 4.5 wt.% to about 50 wt.%, based on the total weight of the composition, and uses and methods thereof. The invention also provides a composition for inhibiting tyrosinase, which comprises oat, coconut powder, white kidney bean, coix seed powder, yam powder, tuckahoe rice flakes, nicotinamide and zinc. The invention also provides application of the composition in preparing a functional preparation for inhibiting tyrosinase production and a method for inhibiting tyrosinase production for non-treatment purposes. The composition disclosed by the invention can realize a higher tyrosinase inhibition rate, so that the generation of melanin is inhibited, and the composition has a good whitening effect.
Description
Technical Field
The present invention relates to compositions for inhibiting tyrosinase, in particular for inhibiting melanin production by inhibiting tyrosinase activity, and uses and methods thereof.
Background
With the increase of age, adverse skin symptoms such as pigmentation, dark yellow skin color and the like are increased, and the improvement of the skin color becomes a problem that oriental women pay more and more attention in the process of pursuing beauty. The skin color is affected by abnormal melanin metabolism, impaired skin barrier, blood circulation stasis, oxygen free radical accumulation, and inflammation. In particular, melanin produced by melanocytes existing between epidermis and dermis is excessive due to the influence of ultraviolet rays or hormones, or melanin removal is inhibited by inflammation or the like, which causes pigment deposition such as speckle, freckle or the like on the skin.
In the prior art, the acidic components such as kojic acid, azelaic acid, vitamin C, linoleic acid and the like are main effective substances for inhibiting melanin formation, but have the characteristics of poor solubility, poor compatibility, instability and the like. The natural plant extracts, such as chamomile extract, liquorice extract, and hedyotis diffusa extract, have the advantages of small irritation, high safety, good curative effect and the like, but are mostly limited in cosmetics, and are easily influenced by factors such as high production cost, small dosage, low skin barrier permeation and absorption utilization rate and the like.
As the traditional diet of Chinese people, the grain is one of the indispensable foods on the dining table of common people for thousands of years, plays an important role in the diet of China and is taken as the traditional staple food. With the pursuit of health and dietary diversification of consumers in modern society, cereals are made into various foods having both health and deliciousness, such as cereal flakes, oatmeal, yogurt containing cereals, beverages, biscuits and the like. The grains are rich in carbohydrate, protein, vitamins and minerals, and have high nutritive value. However, no technique for inhibiting melanin formation has been reported for cereals.
Disclosure of Invention
The invention provides a composition for inhibiting tyrosinase, and applications and methods thereof.
In one aspect, the present invention provides a composition for inhibiting tyrosinase comprising grain in an amount of about 50 wt.% to about 95 wt.% and coconut flour in an amount of about 4.5 wt.% to about 50 wt.%, based on the total weight of the composition.
In some of these embodiments, the composition comprises oat and coconut flour. In some embodiments, the composition further comprises at least one of navy bean, coix seed, yam, poria, niacinamide, and zinc.
In another aspect, the present invention provides a composition for inhibiting tyrosinase comprising oat, coconut flour, navy bean, coix seed flour, yam flour, poria cocos rice flakes, niacinamide, and zinc.
In yet another aspect, the present invention also provides the use of the above composition for the preparation of a functional preparation for inhibiting tyrosinase production.
In yet another aspect, the present invention also provides a method for non-therapeutic purposes of inhibiting tyrosinase production, the method comprising: providing an effective amount of the above composition to a subject in need thereof.
Other features and aspects of the present invention are set forth in more detail below.
Detailed Description
The present invention will be described in further detail below so that those skilled in the art to which the present invention pertains can easily put the present invention into practice. It should be understood, however, that the present invention may be embodied in various forms and is not limited to the specific embodiments described herein, and that the embodiments of the present invention are merely exemplary.
The term "about" or "approximately" as applied to numerical values as described herein encompasses precise values and reasonable variances.
Unless otherwise specified, the terms "include" and "comprise," as well as grammatical variants thereof, are intended to mean "open" or "inclusive" language such that it includes the recited elements but also allows for inclusion of additional, unrecited elements.
All percentages in this specification refer to weight percentages unless otherwise indicated. The expressions "% by weight of …" "% by weight", "% by weight" and "wt.%" are synonyms that refer to the amounts expressed as percentages on a dry weight basis.
The term "effective amount" is a predetermined amount calculated to achieve the desired effect, i.e., to prevent, counter, alleviate, ameliorate, prevent, inhibit, block, or reverse an undesired condition in a patient.
Unless otherwise defined, all terms have, and should be given, the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
Tyrosinase, also known as polyphenol oxidase, is an about 75kD copper-containing oxidoreductase, widely exists in animals, plants, microorganisms and human bodies, is a rate-limiting enzyme for melanin synthesis, and directly influences the synthesis of melanin. The tyrosinase is composed of a plurality of subunits, each subunit contains 2 metallic copper ions, the 2 copper ions are respectively and covalently bonded with imino groups of 3 histidine residues and fixed on an active center, and in addition, 1 endogenous bridge group links the 2 copper ions together to form the active center of the tyrosinase. If the copper is oxidized, the enzyme is inactivated and can be reactivated by means of an electron donor, such as L-3,4 dihydroxyphenylalanine, ascorbic acid, superoxide anion, and possibly nitric oxide. The tyrosinase gene family has 3 kinds of genes in total, namely TYR, TYRP1 and TYRP2, wherein TYRP1 and TYRP2 play a catalytic role in controlling the final steps of melanin type production by melanocytes, TYR is a key rate-limiting enzyme in the initial process of melanin synthesis, and has at least two activities of tyrosine hydroxylase and dopa oxidase, and oxidation and transport of tyrosine are involved in the process of melanin synthesis. Under the catalytic action of tyrosinase, L-tyrosine is hydroxylated into dopa, dopa is oxidized into dopaquinone, and dopaquinone forms the final reaction product melanin. The expression and activity of tyrosinase determines the rate and yield of melanin production, and the higher the tyrosinase activity, the greater the amount of melanin formation in the skin.
Melanin generally plays an important role in protecting the human body from the radiation of ultraviolet rays, and thus, the ultraviolet rays can activate the activity of tyrosinase, and after tyrosine or 3, 4-dihydroxyphenylalanine is oxidized, melanin is formed through the above-mentioned series of chemical reactions. Melanin is continuously produced and deposited and forms uniform melanin particles, thereby making the skin appear darker color, and excessive local production may cause chloasma and freckles. Therefore, the production of melanin can be inhibited by inhibiting the activity of tyrosinase, thereby preventing skin pigmentation.
The reagent with tyrosinase activity inhibition effect can slow down the catalytic conversion of L-tyrosine into dopaquinone by tyrosinase, so that the inhibition effect of a test object on the tyrosinase activity can be evaluated by measuring the absorbance of the dopaquinone at 475nm according to the change of the absorbance, thereby evaluating the inhibition effect on the melanin generation.
The invention relates to a composition for inhibiting tyrosinase, which comprises raw materials such as grains and coconut powder. By selectively controlling various aspects of the composition, the inventor finds that the obtained composition can realize higher tyrosinase inhibition rate, thereby inhibiting the generation of melanin and having good whitening effect. The inventors have also found that the combined use of grain and coconut flours provides a higher tyrosinase inhibition than the use of the same amount of grain and coconut flours alone, indicating a synergistic effect of the combined use of grain and coconut flours.
As used herein, the term "grain" refers to a monocotyledonous or dicotyledonous plant grown for its edible seed, including plants selected from the group consisting of rice (Oryza), wheat (Triticum) belonging to the family Poaceae (Poaceae), and combinations thereof. The grains suitable for use in the present invention may be selected from, for example, glutinous rice, brown rice, black rice, purple rice, oat, buckwheat, barley, whole wheat, sorghum rice, millet, or the like. In some embodiments, the grain is selected from at least one of oat, brown rice, and rice. In other embodiments, the cereal comprises oat and brown rice. In still other embodiments, the cereal comprises oats and rice. In some embodiments, the cereal is oat.
The form of the grain is not particularly limited and may be adjusted as desired, and includes, but is not limited to, powder, granules, flakes, suspension, cakes, and the like. In some embodiments, when the composition is a food composition, the grain may be a powder, granules, flakes, chunks, or the like.
"oats" refers to annual herbaceous plants of the genus Avena (Avena L.) of the family Gramineae, and is generally classified into the palea type (oats husked) and the grain type (oats naked). Oat is rich in various nutritional ingredients such as protein, fat, carbohydrate, vitamins and trace elements, and compared with crops such as wheat, rice, corn, barley and sorghum, the five index contents of protein, fat, mineral elements, cellulose and vitamins in grains of oat are in the top position. In addition, the amino acid composition of the oat flour protein is relatively balanced, wherein the content of lysine is 1.5-3.0 times higher than that of grain crops such as wheat. The oat also contains natural antioxidants such as polyphenol, enrichin, tocopherol and carotenoid, has excellent effects of resisting oxidation and eliminating free radicals in vivo, and the colloidal extract can remarkably increase skin moisture and improve dry and rough skin.
For convenience of description, the present invention uses the term "coconut flour", but is not intended to be limited to the powder form, but may be coconut milk, coconut juice, coconut milk powder, etc. In the present invention, the coconut powder may be derived from coconut meat, coconut extract, coconut milk, and the like. Coconut meat contains abundant vitamins, minerals, free amino acids, enzymes and growth promoting factors, wherein L-arginine and polyphenol compounds have strong scavenging capacity on superoxide anion free radicals, DPPH free radicals and hydroxyl free radicals. The coconut extract can promote the expression of skin keratinocyte components to increase the protective barrier effect of stratum corneum after medium-wave ultraviolet irradiation. In addition, coconut flour has a natural sweet taste and can be added to food compositions as a sweetener. In some embodiments of the invention, the composition is free of sweeteners other than coconut flour.
Specifically, in the composition, the cereal is present in an amount of about 50 wt.% to about 95 wt.% and the coconut flour is present in an amount of about 4.5 wt.% to about 50 wt.%, based on the total weight of the composition. In some embodiments, the cereal is present in the composition in an amount of about 60 wt.% to about 95 wt.% and the coconut flour is present in an amount of about 4.5 wt.% to about 15 wt.%, based on the total weight of the composition. In some embodiments, the cereal is present in the composition in an amount of about 65 wt.% to about 90 wt.% and the coconut flour is present in an amount of about 6 wt.% to about 13 wt.%, based on the total weight of the composition. In some embodiments, the cereal is present in the composition in an amount of about 65 wt.% to about 85 wt.% and the coconut flour is present in an amount of about 7 wt.% to about 12 wt.%, based on the total weight of the composition. In some embodiments, the cereal is present in the composition in an amount of about 70 wt.% to about 80 wt.% and the coconut flour is present in an amount of about 8 wt.% to about 10 wt.%, based on the total weight of the composition. In some embodiments, the cereal is present in the composition in an amount of about 75 wt.% to about 80 wt.% and the coconut flour is present in an amount of about 9 wt.% to about 10 wt.%, based on the total weight of the composition.
In order to enhance the efficacy of the composition, the composition can also comprise suitable medicinal and edible raw materials. As used herein, the term "raw materials having homology of medicine and food" refers to raw materials that are included in "the material catalog management regulation according to the tradition of both foods and traditional Chinese medicinal materials" published by the national standard for safety of health and welfare food and testing evaluation in 2021, have both nutritive value and medicinal value, and are widely researched and applied in the fields of general foods, medicines and functional foods. In some embodiments, the medicinal and edible raw materials may include, but are not limited to, at least one of white kidney bean, red bean, tremella, coix seed, yam, poria, lotus seed, lily, and pueraria root. In other embodiments, the medicinal and edible raw materials may include at least one of white kidney bean, white fungus, coix seed, Chinese yam and poria cocos. In other embodiments, the medicinal and edible raw materials may include at least one of tremella, coix seed, yam, and poria. In other embodiments, the medicinal and edible material may comprise at least one of navy bean, coix seed, yam, and poria. In other embodiments, the medicinal and edible raw materials may include at least one of tremella, coix seed, lotus seed, and poria.
In order to exert the effects of the medicinal and edible raw materials per se without affecting the overall texture or mouthfeel of the composition, the content of the medicinal and edible raw materials is preferably about 2 wt.% to about 25 wt.%, based on the total weight of the composition. In some embodiments, the amount of the edible and pharmaceutical raw material is from about 8 wt.% to about 15 wt.%. In other embodiments, the amount of the edible and pharmaceutical raw material is from about 10 wt.% to about 12 wt.%.
These medicated homologous materials will be described in detail below.
White kidney bean (Phaseolus lunatus Billb. ex Bean.) belongs to subfamily of Papilionaceae of Leguminosae and Phaseolus vulgaris, is a bean crop widely planted in the world, and has 18-21% of protein, 40-60% of starch and 1.6-2.15% of fat in kidney bean seeds, so that the white kidney bean is rich in nutrition and has medicinal value. The white kidney bean contains amylase inhibitor, can inhibit the activity of amylase in saliva and prevent the hydrolysis and digestion of carbohydrate in food, and is widely applied to health-care food for losing weight, controlling blood sugar and the like. In the examples of the present invention, the form of white kidney beans is not particularly limited, and may be powder, flakes, slurry, or the like.
Semen Phaseoli (Abrus precatorius L.) is seed of red bean of Leguminosae, also called semen Phaseoli and semen Phaseoli. The red bean contains rich nutrient elements such as protein, carbohydrate, fat, dietary fiber, various vitamins, carotene, inorganic salt and the like, and has the effects of relaxing bowels, promoting urination, promoting normal development of bones and teeth, nourishing five internal organs, maintaining beauty and keeping young and the like. In the embodiment of the present invention, the form of red beans is not particularly limited, and may be powder, flake, slurry, or the like.
Tremella fuciformis Berk is a fruiting body of basidiomycota fungus Tremella, consists of more than 10 thin and multi-fold flat leaves, is also called Tremella fuciformis, Tremella fuciformis and the like, has the name of 'crown in fungus', is a famous and precious nutritional nourishing product, and is a tonic for strengthening body resistance. Mild in nature, sweet and light in taste, and non-toxic. Has effects in moistening lung, promoting salivation, nourishing yin, invigorating stomach, invigorating qi, tranquilizing mind, tonifying heart, and strengthening brain. Tremella contains abundant proteins, vitamins, etc., so the Tremella powder has effects of resisting aging, removing wrinkle and firming skin, and can be used for removing freckle, chloasma, etc. when being applied. In the embodiment of the present invention, the form of tremella is not particularly limited, and may be powder, flake, slurry, etc. In some embodiments, when used as a food composition, tremella improves the texture of the composition, making it rich in a smooth mouthfeel.
Coix lacryma-jobi L is dried mature kernel of a plant belonging to genus Coix of family Gramineae. Sweet and light taste, cool in nature, and has the effects of promoting diuresis, invigorating spleen, relieving diarrhea, eliminating arthralgia, expelling pus, removing toxic substance, and resolving hard mass. The Coicis semen contains Coix seed oil, Coix seed ester, amino acids, fatty oil, etc. Coix seed oil and coixol have muscle contraction inhibiting effect, and coixol also has tranquilizing, antipyretic, cooling and analgesic effects on central nervous system. The extract of Coicis semen can enhance humoral immunity, enhance NK cell activity or cytotoxicity, and has antiviral and anticancer effects. In addition, experiments prove that the medicine has the effect of inducing ovulation and can reduce blood sugar. A heat stable protease inhibitor was also found from the soft-shelled coixseed bran. In the embodiment of the present invention, the form of the coix seed is not particularly limited, and may be powder, tablet, slurry, etc.
Rhizoma Dioscoreae (Dioscorea opposita) is dried rhizome of Dioscorea opposita of Dioscoreaceae. Can be used for treating epidemic febrile disease, fever, bloody dysentery, carbuncle, ulcer, toxic swelling, lymphoid tuberculosis, and anal fistula. Contains nutrients related to mucus and amylase, and has tonic and digestion promoting effects. In the examples of the present invention, the form of yam is not particularly limited, and may be powder, tablet, slurry, or the like.
Poria cocos (Wolfipora cocos (Schw.) Ryv. & Gibn) is a fungus plant parasitic on pine roots, shaped like a sweet potato, dark brown in the outer skin, white or pink in the inner side. Poria has sweet and light taste and mild nature, and has effects of promoting diuresis, eliminating dampness, invigorating spleen, regulating stomach function, calming heart, tranquilizing mind, and whitening skin. Modern medical research shows that tuckahoe can enhance the immune function of organisms, and pachyman has obvious anti-tumor and liver-protecting effects. In the embodiment of the present invention, the form of poria cocos is not particularly limited, and may be powder, tablet, slurry, or the like. In some embodiments, when used as a food composition, the poria may be mixed with brown rice or rice to make poria rice flakes to enhance the crispy mouthfeel of the composition.
Semen Nelumbinis (Semen Nelumbini) is dry mature seed of Nymphaeaceae aquatic herbaceous plant flos Nelumbinis, also called Semen Nelumbinis, and Semen Nelumbinis. The lotus seed is rich in nutrition, and contains beta-sitosterol, alkaloid, rich mineral substances such as calcium, phosphorus, iron and the like and vitamins besides a large amount of starch. Modern pharmacological research also proves that the lotus seeds have various effects of calming, strengthening heart, resisting aging and the like. In the embodiment of the present invention, the form of the lotus seed is not particularly limited, and may be powder, flake, slurry, or the like.
Lily (Lilium brownii var. virididuum) is fleshy scaly leaf of Lilium brownii (Lilium lancifolium Thunb.) plant, lily (Lilium brownii f.e. brown var. virididum Baker) or Lilium microphyllum DC (Lilium pullium DC.) and has the effects of nourishing yin, moistening lung, clearing heart and tranquilizing mind. It is often used to treat dry cough due to yin deficiency, cough with blood, vexation, pavor, insomnia, dreaminess, absentmindedness. In the examples of the present invention, the form of lily is not particularly limited, and may be powder, tablet, slurry, or the like.
Radix Puerariae (Radix Puerariae) is a Leguminosae plant Pueraria lobata, has cool nature, mild smell and sweet taste, and has effects of clearing heat, lowering fire, removing toxic substance, etc. Further analysis by modern medical methods shows that the root of kudzu vine is rich in up to 13 isoflavones, including puerarin, miroestrol, puerarin xyloside, daidzein, etc., and puerarin has therapeutic effects on hypertension, hyperlipidemia, hyperglycemia and cardiovascular and cerebrovascular diseases. Puerarin can lower blood sugar and obviously lower serum cholesterol. In the embodiment of the present invention, the form of pueraria lobata is not particularly limited, and may be powder, tablet, slurry, etc.
To further enhance the nutritional efficacy of the composition, the composition may further comprise at least one suitable nutritional enhancer. In some embodiments, the nutritional fortifier may be present in an amount of about 0.01 wt.% to about 1.5 wt.%, based on the total weight of the composition. In other embodiments, the nutritional supplement may be present in an amount of about 0.05 wt.% to about 1 wt.%, based on the total weight of the composition. In some embodiments, the at least one nutritional enhancer may be selected from at least one of dairy products, niacinamide, vitamins, and trace elements.
The dairy product may be, for example, cow's milk, goat's milk, yogurt, cheese, or the like. In some particular embodiments, the dairy product is milk. The form of the dairy product is not particularly limited, and may be a powder, a cake, a liquid, a semisolid form, or the like.
Nicotinamide is a derivative of vitamin B3, is widely used for treating pellagra, light dermatitis and cosmetic dermatitis in clinic, can improve skin quality by inhibiting melanin from transferring to keratinocytes and accelerating skin cell metabolism, and can be used in cosmetics, foods and pharmaceuticals. When the composition of the invention is a food composition, the nicotinamide is a food grade nicotinamide.
The trace elements include trace elements necessary for human body, such as iron, copper, zinc, calcium, magnesium, sodium, cobalt, manganese, chromium, selenium, iodine, nickel, fluorine, molybdenum, vanadium, tin, silicon, strontium, boron, rubidium, arsenic, etc. In some embodiments, the trace elements are selected from at least one of zinc, iron, calcium, magnesium, sodium. In some particular embodiments, the trace element is zinc. Zinc is an important trace element necessary for human body, and is helpful for growth and development, intelligence development, immunity improvement, and normal appetite maintenance.
Vitamins include, for example, but are not limited to, at least one of vitamin a, vitamin B, vitamin C, vitamin D, vitamin E. In some embodiments, the vitamin may be selected from at least one of vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin B9, and vitamin B7. In some embodiments, the vitamin is vitamin B2. Vitamin B2, also called riboflavin, is a water-soluble vitamin which is easy to digest and absorb and has the effects of curing canker sores and maintaining mucous membrane health.
In some of these embodiments, exemplary formulations of the compositions of the present invention are shown in table 1 below.
TABLE 1 exemplary formulations of the compositions of the present invention
In some embodiments of the above formulation, the oat, coix seed, yam, poria, lotus seed, etc. may be in powder form for ease of mixing and absorption.
The composition of the invention can be used alone as a functional preparation, for example as a nutritional supplement or dietary fibre supplement or the like. In addition, the composition can be ingested as a food product, such as a cereal porridge, cereal flakes, beverage, yogurt, and the like. In particular embodiments, the composition may be a mixed instant oatmeal that may satisfy the health, beauty and convenience needs of modern fast-paced urban women.
The invention also relates to a composition for inhibiting tyrosinase, which comprises oat, coconut powder, white kidney bean, coix seed powder, yam powder, tuckahoe rice flakes, nicotinamide and zinc. By selectively controlling the content of each component of the composition, the inventor finds that the obtained composition can realize higher tyrosinase inhibition rate, thereby inhibiting the generation of melanin and having good whitening effect. The inventors have also found that the tyrosinase inhibition rate of the combination of oat and coconut flour is higher than that of the same amount of oat and coconut flour alone, indicating that the combination of grain and coconut flour has a synergistic effect.
In some embodiments, the composition consists of, based on the total weight of the composition: oat: about 50 wt.% to about 95 wt.%, coconut flour: about 4.5 wt.% to about 50 wt.%, white kidney bean: about 6 wt.% to about 15 wt.%, coix seed powder: about 0.7 wt.% to about 10 wt.%, yam flour: about 1 wt.% to about 10 wt.%, poria cocos rice flakes: about 6 wt.% to about 25 wt.%, zinc nicotinamide: about 0.01 wt.% to about 0.5 wt.%. In other embodiments, the composition consists of, based on the total weight of the composition: oat: about 62 wt.% to about 75 wt.%, coconut flour: about 4.5 wt.% to about 15 wt.%, white kidney bean: about 6 wt.% to about 15 wt.%, coix seed powder: about 0.7 wt.% to about 2.1 wt.%, yam flour: about 1 wt.% to about 2 wt.%, poria cocos rice flakes: about 11 wt.% to about 18.4 wt.%, zinc nicotinamide: about 0.01 wt.% to about 0.5 wt.%. In a particular embodiment, the composition consists of, based on the total weight of the composition: oat: about 70.15 wt.%, coconut flour: about 9.3 wt.%, white kidney bean: about 6 wt.%, coix seed powder: about 2 wt.%, yam flour: about 1.5 wt.%, poria cocos rice flakes: about 11 wt.%, zinc nicotinamide: about 0.05 wt.%.
The composition of the present invention may be a food composition or a functional preparation. In some embodiments, the composition is free of sweeteners other than coconut flour. When used as a food composition, the coconut powder has light fragrance and natural sweet taste due to its natural coconut powder, and is free of sweeteners such as sucrose and honey, low in calorie, and healthy and delicious. The composition has the efficacy of eliminating dampness and nourishing, has beautiful vision and is more popular with consumers because of containing white medicinal and edible raw materials such as white kidney beans, coix seed powder, yam powder, tuckahoe rice flakes and the like.
The invention also relates to application of the composition in preparing a functional preparation for inhibiting tyrosinase production. The functional agent may be, for example, a cosmetic agent, a food agent, a pharmaceutical agent, or the like. Since melanin is generally generated by the action of tyrosinase on tyrosine, the generation of melanin can be inhibited by inhibiting the generation of tyrosinase, thereby achieving the effect of whitening skin. Therefore, the composition can be used for preparing a functional preparation for inhibiting melanin generation.
The present invention also relates to a method for non-therapeutic purposes of inhibiting tyrosinase production, the method comprising: providing an effective amount of the above composition to a subject in need thereof. Means provided include, but are not limited to, oral administration, topical administration, and the like. In some embodiments, the method of non-therapeutic interest comprises orally administering to a subject in need thereof an effective amount of the above composition to inhibit melanin production.
Hereinafter, the composition of the present invention will be described in detail with reference to specific examples, but the present invention is not limited thereto. Unless otherwise indicated, the raw materials and chemicals in the following examples are food grade and are from commercially available products.
Examples
Example 1: taste and mouthfeel evaluation of Mixed oatmeal
The formulation of the mixed oatmeal of this example is shown in table 2 below.
TABLE 2 formulation of Mixed oatmeal of example 1
Components | Weight (g) | Percent (wt.%) |
Oatmeal | 24.55 | 70.15 |
Coconut powder | 3.26 | 9.30 |
Poria cocos rice tablet | 3.85 | 11.00 |
White kidney bean | 2.10 | 6.00 |
Coix seed powder | 0.70 | 2.00 |
Yam powder | 0.53 | 1.50 |
Nicotinamide zinc | 0.02 | 0.05 |
Total of | 35.00 | 100.00 |
The mixed oatmeal of this example was brewed with hot water at 90 ℃ or higher for about 3 to about 5 minutes, and then consumed and evaluated for sweetness and mouthfeel by 20 tasters. The evaluation results are summarized in table 3 below.
TABLE 3 taste test results for the blended oatmeal of example 1
Is very satisfactory | Satisfaction | In general terms | Is unsatisfactory | |
Sweetness level | 17 | 2 | 1 | 0 |
Taste of the product | 16 | 3 | 1 | 0 |
As can be seen from the above table, most of the members evaluated the sweetness and mouthfeel of the mixed oatmeal of this example better. The mixed oatmeal is easy to be brewed, has smooth taste, has the faint scent of coconut and natural sweetness.
Example 2: tyrosinase activity inhibition assay (in vitro method)
The mixed oatmeal of example 1 and the combination of oatmeal, coconut flour, zinc nicotinate, and oat coconut flour therein were each tested for tyrosinase activity inhibition.
The reagents used in this example were as follows: distilled water; phosphate Buffered Saline (PBS): pH 6.8, 0.1 mol/L; l-tyrosine: analytically pure, T3754, purity > 98%, supplied by Sigma company; tyrosinase, and (c) an enzyme: t3824, 1000 units/mg, supplied by Sigma Inc.; kojic acid: s30151, available from Shanghai-derived leaf Biotechnology, Inc.
1. Experimental methods
The ingredients and percentages of the blended oatmeal are as set forth in the formula of table 2, and the oat and coconut flours in the oat coconut flour combination are also in accordance with the mutual mass ratios in table 2, being about 88.3 wt.% and about 11.7 wt.%, respectively. Respectively grinding oatmeal, coconut powder, oat coconut powder, and mixed oatmeal with nanometer grinder. Weighing oatmeal, coconut powder, oat and coconut powder combination, 70.71mg of mixed oatmeal grinding powder, 9.3mg of mixed oatmeal grinding powder, 79.45mg of mixed oatmeal grinding powder and 100mg of mixed oatmeal grinding powder into a 10mL volumetric flask, respectively adding PBS solution, carrying out ultrasonic treatment at 37 ℃ for 30min, fixing the volume to 10mL, transferring to a 15mL centrifuge tube, carrying out vortex centrifugation for 5min, and preparing suspension to be tested. Weigh 0.05mg zinc nicotinamide, dissolve in 1000mL PBS solution, mix well to be tested. The amounts and dilution times of the samples are shown in Table 4.
TABLE 4 sample weighing and dilution factor
A96-well microplate is provided with a solvent bottom well (Ta), a solvent reaction well (Tb), a sample bottom well (Tc), and a sample reaction well (Td). Wherein, the Ta group is a solvent background group, and a substrate L-tyrosine solution and a sample solution are not added; the Tb group is a solvent reaction group, and the substrate L-tyrosine solution is added but no sample solution is added; the Tc group is a sample background group, and a substrate L-tyrosine solution and a sample solution are not added; td group is the sample reaction group, to which both the substrate L-tyrosine solution and the sample solution are added. Each group was plated with three replicate wells and the mean was taken. At the same time, a positive control group of kojic acid solution and a blank control group except for the sample were set at the following doses, and 3 replicates were set.
Weighing 0.025g L-tyrosine, dissolving with PBS buffer solution, ultrasonic-assisted dissolving for 5min, and diluting to 50mL to obtain L-tyrosine solution. Weighing 2.5mg of tyrosinase, and diluting the PBS solution to 5mL to obtain a tyrosinase solution, and preserving at-20 ℃ to avoid secondary freeze thawing. Weighing 40mg of kojic acid, fixing the volume of the PBS solution to 1L, preparing the standard solution of 0.040g/L of kojic acid, gradually diluting the PBS solution in a gradient manner, and finally preparing the standard solution of 0.040g/L, 0.050g/L, 0.010g/L, 0.008g/L, 0.005g/L and 0.002 g/L.
According to table 5, PBS solution, L-tyrosine solution and 5 sample suspensions with corresponding volumes are sequentially added into a 2.5mL centrifuge tube, after oscillation and uniform mixing, the mixture is incubated in a 37 ℃ incubator for 10min, 40 mul of tyrosinase solution is added into each hole, uniform mixing is carried out, the mixture is incubated in the 37 ℃ incubator for 5min, the mixture is centrifuged for 5min at 20000r/min in a 4 ℃ refrigerated centrifuge, 100 mul of each sample is added into a 96-hole ELISA plate, an ELISA reader (BioTek F4 ELISA reader, Baote, USA) is used for detecting the absorbance OD value of each hole, and the detection wavelength is set to 475 nm. The wells were kept consistent (5 min. + -.5 s) from the addition of the tyrosinase solution to the measurement of absorbance.
Each batch of the test requires the addition of a positive control test, the IC of the positive control kojic acid 50 The test system is considered to be effective when the concentration of the compound is 0.005g/L to 0.03 g/L.
TABLE 5 tyrosinase activity inhibition test sample application table
The tyrosinase activity inhibition rate was calculated as follows:
in the formula: y is the tyrosinase activity inhibition rate; a. the d Absorbance of the sample reaction well; a. the c Absorbance of the sample background wells; a. the b Is the average value of absorbance of the solvent reaction wells; a. the a The absorbance average of the background wells of the solvent is shown.
2. Results of the experiment
This positive control kojic acid IC 50 The corresponding concentration was 0.014557g/L, ranging from 0.005g/L to 0.03g/L, and the test system was considered to be effective.
The results of tyrosinase inhibition assay for 5 samples were averaged in triplicate, as shown in table 6.
TABLE 6 sample concentration and tyrosinase activity inhibition
As can be seen from the detection results, the tyrosinase inhibition rates of the oats, the coconut powder and the nicotinamide which are independently used are respectively about 11.62%, about 8.44% and about 1.54%; the tyrosinase inhibition rate of the oat coconut powder used in combination is about 23.93%, which is far greater than the sum of the inhibition rates of the oat and the coconut powder used alone, and a certain synergistic effect is presented; the tyrosinase inhibition rate of the mixed oatmeal is about 23.79%, the inhibition effect of the mixed oatmeal is not very different when the mixed oatmeal is combined with oat coconut powder, and the two components of the oat and coconut powder which play a main role in inhibiting tyrosinase in the mixed oatmeal are shown, which is probably related to the fact that the total ratio of the oat and coconut powder components in the mixed oatmeal is higher.
However, it is understood by those skilled in the art that other ingredients in the oatmeal can still supplement other nutrition, for example, white kidney beans have the functions of eliminating dampness and blocking starch absorption, coix seeds have the functions of whitening and eliminating dampness, Chinese yam has the functions of nourishing and promoting digestion, poria cocos has the functions of whitening and enhancing the immune function of the organism, and zinc is helpful for growth and development, intelligence development and immunity improvement.
The mixed oatmeal disclosed by the invention is added with the zinc nicotinamide on the basis that the oat, the coconut powder and the like can be directly added into food products, and is reasonably matched with raw materials with whitening effects in a medicine-food homologous list, so that the purpose of improving the skin state is achieved by an edible mode. Through detection, the mixed oatmeal has a certain inhibition effect on tyrosinase, the inhibition rate of the mixed oatmeal is lower than the effects of common medicines or plant extracts such as tranexamic acid, vitamin C, arbutin and the like, but the abnormal reactions of rash, digestive systems and the like caused by the tranexamic acid and the dosage limit requirement of the plant extracts, particularly part of traditional Chinese medicine extracts in food addition are effectively avoided.
The technical features of the embodiments described above may be arbitrarily combined, and for the sake of brevity, all possible combinations of the technical features in the embodiments described above are not described, but should be considered as being within the scope of the present specification as long as there is no contradiction between the combinations of the technical features.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.
Claims (23)
1. A composition for inhibiting tyrosinase comprising a cereal in an amount of 50 wt.% to 95 wt.% and coconut flour in an amount of 4.5 wt.% to 50 wt.%, based on the total weight of the composition.
2. The composition as defined in claim 1, wherein said grain is present in an amount of 60 wt.% to 95 wt.% and said coconut flour is present in an amount of 4.5 wt.% to 15 wt.%, based on the total weight of said composition.
3. The composition as defined in claim 1, wherein said grain is present in an amount of 65 wt.% to 85 wt.% and said coconut flour is present in an amount of 7 wt.% to 12 wt.%, based on the total weight of said composition.
4. The composition as defined in claim 1, wherein said grain is present in an amount of 70 wt.% to 80 wt.% and said coconut flour is present in an amount of 8 wt.% to 10 wt.%, based on the total weight of said composition.
5. The composition of claim 1, wherein the grain is selected from at least one of oat, brown rice, and rice.
6. The composition of claim 1, further comprising at least one of navy bean, red bean, tremella, coix seed, yam, tuckahoe, lotus seed, lily, and kudzu root.
7. The composition according to claim 1, characterized in that it further comprises at least one nutritional enhancer.
8. The composition according to claim 7, wherein the at least one dietary supplement is selected from at least one of dairy products, niacinamide, vitamins, and trace elements.
9. The composition of claim 8, wherein the trace element is selected from at least one of zinc, iron, calcium, magnesium, and sodium.
10. The composition of claim 9, wherein the trace element is zinc.
11. The composition of claim 8, wherein said vitamin is vitamin B2.
12. The composition of claim 1 wherein the composition is mixed instant oatmeal.
13. A composition for inhibiting tyrosinase comprises oat, coconut flour, navy bean, coix seed flour, yam flour, poria cocos rice flakes, niacinamide and zinc.
14. The composition according to claim 13, characterized in that it consists of, based on the total weight of the composition:
oat: 50 wt.% to 95 wt.%, coconut flour: 4.5 wt.% to 50 wt.%, white kidney bean: 6-15 wt.%, coix seed powder: 0.7 wt.% to 10 wt.%, yam flour: 1 wt.% to 10 wt.%, poria cocos rice flakes: 6 wt.% to 25 wt.%, zinc nicotinamide: 0.01 wt.% to 0.5 wt.%.
15. The composition according to claim 13, characterized in that it consists of, based on the total weight of the composition:
oat: 62 wt.% to 75 wt.%, coconut flour: 4.5 wt.% to 15 wt.%, white kidney bean: 6-15 wt.%, coix seed powder: 0.7 wt.% to 2.1 wt.%, yam flour: 1 wt.% to 2 wt.%, poria cocos rice flakes: 11 wt.% to 18.4 wt.%, zinc nicotinamide: 0.01 wt.% to 0.5 wt.%.
16. The composition according to claim 15, wherein the composition consists of, based on the total weight of the composition:
oat: 70.15 wt.%, coconut flour: 9.3 wt.%, white kidney bean: 6 wt.%, coix seed powder: 2 wt.%, yam flour: 1.5 wt.%, poria cocos rice flakes: 11 wt.%, zinc nicotinamide: 0.05 wt.%.
17. The composition according to any one of claims 1 to 16, wherein the composition is a food composition or a functional preparation.
18. A composition according to any one of claims 1 to 16, wherein the composition is for use in inhibiting melanin.
19. Use of a composition according to any one of claims 1-18 for the preparation of a functional formulation for inhibiting tyrosinase production.
20. The use according to claim 19, wherein the composition is used for the preparation of a functional preparation for inhibiting melanogenesis.
21. A method for non-therapeutic purposes of inhibiting tyrosinase production, comprising: providing an effective amount of the composition of any one of claims 1-18 to a subject in need thereof.
22. The method of non-therapeutic purpose according to claim 21, comprising: orally administering to a subject in need thereof an effective amount of the composition.
23. The non-therapeutic method of claim 21, wherein the non-therapeutic method is for inhibiting melanogenesis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210519924.7A CN114794469A (en) | 2022-05-12 | 2022-05-12 | Compositions for inhibiting melanin and uses and methods thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210519924.7A CN114794469A (en) | 2022-05-12 | 2022-05-12 | Compositions for inhibiting melanin and uses and methods thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114794469A true CN114794469A (en) | 2022-07-29 |
Family
ID=82516296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210519924.7A Pending CN114794469A (en) | 2022-05-12 | 2022-05-12 | Compositions for inhibiting melanin and uses and methods thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114794469A (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100841072B1 (en) * | 2007-01-15 | 2008-06-24 | 유지은 | Natural grain skin whitening composition |
CN105795249A (en) * | 2014-12-31 | 2016-07-27 | 姜汉成 | Tartary buckwheat-coconut nutrition powder and preparation method thereof |
CN106360233A (en) * | 2016-08-29 | 2017-02-01 | 宁波御坊堂生物科技有限公司 | Meal replacement solid drink and preparation method thereof |
CN109221943A (en) * | 2018-09-13 | 2019-01-18 | 黄桂英 | A kind of mixing oatmeal and preparation method thereof |
CN109380735A (en) * | 2017-08-08 | 2019-02-26 | 陈声贵 | A kind of full nutritious food |
CN109673951A (en) * | 2019-02-20 | 2019-04-26 | 徐淑蕾 | A kind of the coconut oat instant food and preparation method of glutinous cunning |
CN111296736A (en) * | 2020-03-02 | 2020-06-19 | 山东阳平食品有限公司 | Coconut powder walnut oat porridge |
CN111602722A (en) * | 2020-05-12 | 2020-09-01 | 安徽顺鑫盛源生物食品有限公司 | Nutritional instant rice milk powder and preparation method thereof |
CN111632003A (en) * | 2020-07-10 | 2020-09-08 | 广州广美依医疗科技有限公司 | Cosmetic composition with whitening effect |
-
2022
- 2022-05-12 CN CN202210519924.7A patent/CN114794469A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100841072B1 (en) * | 2007-01-15 | 2008-06-24 | 유지은 | Natural grain skin whitening composition |
CN105795249A (en) * | 2014-12-31 | 2016-07-27 | 姜汉成 | Tartary buckwheat-coconut nutrition powder and preparation method thereof |
CN106360233A (en) * | 2016-08-29 | 2017-02-01 | 宁波御坊堂生物科技有限公司 | Meal replacement solid drink and preparation method thereof |
CN109380735A (en) * | 2017-08-08 | 2019-02-26 | 陈声贵 | A kind of full nutritious food |
CN109221943A (en) * | 2018-09-13 | 2019-01-18 | 黄桂英 | A kind of mixing oatmeal and preparation method thereof |
CN109673951A (en) * | 2019-02-20 | 2019-04-26 | 徐淑蕾 | A kind of the coconut oat instant food and preparation method of glutinous cunning |
CN111296736A (en) * | 2020-03-02 | 2020-06-19 | 山东阳平食品有限公司 | Coconut powder walnut oat porridge |
CN111602722A (en) * | 2020-05-12 | 2020-09-01 | 安徽顺鑫盛源生物食品有限公司 | Nutritional instant rice milk powder and preparation method thereof |
CN111632003A (en) * | 2020-07-10 | 2020-09-08 | 广州广美依医疗科技有限公司 | Cosmetic composition with whitening effect |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101776071B1 (en) | Composition containing red sword bean extract for anti-aging and whitening | |
EP3626249A2 (en) | Traditional chinese medicine healthcare preparation for fat elimination and weight reduction | |
WO2016192507A1 (en) | Composition having whitening effect and application thereof | |
CN105532998A (en) | Health-care tea containing cordyceps militaris and preparation method thereof | |
CN111902049A (en) | Health beverage composition having excellent hangover alleviating effect and preventing liver damage due to alcohol | |
US20100068184A1 (en) | Living body healing accelerator | |
KR102306737B1 (en) | Antioxidant food comprising extracts of fresh sprouts of Xanthium canadense Mill. | |
CN109497227A (en) | A kind of brown sugar Qi jujube Health care ginger tea | |
JP2011055837A (en) | Food and drink for beautification | |
EP3766363A1 (en) | Composition for improving skin conditions | |
JP4703832B2 (en) | Collagen production promoter, estrogen-like agent, collagenase inhibitor, skin cosmetic and food and drink | |
KR102167958B1 (en) | Composition for prevention and treatment of muscular disorders or improvement of muscular functions comprising extract of Amaranthus spp. or grain cereals | |
CN104352542A (en) | Sea cucumber and saussurea involucrata composition preparation and preparation method thereof | |
KR20090081062A (en) | Diabetic preventive treatment and visceral function therapeutic composition and preparation method thereof | |
KR20170086198A (en) | Manufacturing method of diet solid tea including fermentation herb remedy and dietary fiber and the solid tea produced thereby | |
JP2003137801A (en) | Collagen production promoter, collagenase inhibitor, fibroblast cell-propagating agent, skin cosmetic material and food or beverage for cosmetic use | |
CN114794469A (en) | Compositions for inhibiting melanin and uses and methods thereof | |
KR101865142B1 (en) | Pharmaceutical composition containing combination extract of Spiraea prunifolia, Pyrus pyrifolia and Geum japonicum for prevention and treatment of allergic diease | |
KR20040097813A (en) | Composition containing Diet Neurotrophic Factor having anti-fatness functions | |
JP6141071B2 (en) | Skin moisture increasing agent | |
CN113545405A (en) | Instant blood-replenishing and beauty-maintaining tea and preparation method thereof | |
US20220193163A1 (en) | Composition comprising actinidia polygama extract for alleviating skin damage or moisturizing skin | |
CN112674332A (en) | Antioxidant composition containing folic acid and nutrition tablet | |
KR20040090644A (en) | Cosmetic composition containing grain extract and fermented grain phellinus linteus extract, and cosmetics containing the same | |
KR102670653B1 (en) | Composition for improving hair loss containing fermented product of lactic acid bacteria of Helianthus tuberosus extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |